ASSOCIATION BETWEEN AVERAGE WEEKLY CONVECTION VOLUME AND MORTALITY IN HYBRID HEMODIAFILTRATION–HEMODIALYSIS REGIMENS

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

Presented the abstract " "
(Abstract co-author(s): )

Back

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.

E-Poster Format Requirements

PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos

E-Poster

https://storage.unitedwebnetwork.com/files/1099/5a648a9a23eab2288085042a70c718c2.pdf

Abstract Title *

ASSOCIATION BETWEEN AVERAGE WEEKLY CONVECTION VOLUME AND MORTALITY IN HYBRID HEMODIAFILTRATION–HEMODIALYSIS REGIMENS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

The title will not be accepted if it exceeds 25 words.
Type in CAPITAL LETTERS.
Lowercase may be used for abbreviations only, for example, mRNA.

Co-author 1

Wangshu Wu wangshu0825@qq.com Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -

Co-author 2

Yan Fang fangyan_fyfy@126.com Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -

Co-author 3

Haifen Zhang haifenzhang@163.com Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -

Co-author 4

Weiming Zhang weimingzh1965@163.com Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -

Co-author 5

Qidi Zhang qidi17@sjtu.edu.cn Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -

Co-author 6

Xufei Xiang xiangxufei2022@163.com Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -

Co-author 7

Yuedong Wang yuedong@pstat.ucsb.edu University of California University of California California United States -

Co-author 8

Hanjie Zhang Hanjie.Zhang@RRINY.COM Renal Research Institute, LLC, New York Renal Research Institute, LLC, New York New York United States -

Co-author 9

Len Usvyat Len.Usvyat@rriny.com Renal Research Institute, LLC, New York Renal Research Institute, LLC, New York New York United States -

Co-author 10

Qing Lin qing.lin@freseniusmedicalcare.com Fresenius Medical Care (Shanghai) Co., Ltd Global Medical Office, Clinical Research Shanghai China -

Co-author 11

Weiwei Qi weiwei.qi@freseniusmedicalcare.com Fresenius Medical Care (Shanghai) Co., Ltd Global Medical Office, Clinical Research Shanghai China *

Co-author 12

Yucheng Yan grace.yan@freseniusmedicalcare.com Fresenius Medical Care (Shanghai) Co., Ltd Global Medical Office, Clinical Affairs Shanghai China -

Co-author 13

Renhua Lu lurenhua1977@hotmail.com Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -

Co-author 14

Huihua Pang panghuihua@renji.com Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -

Co-author 15

Leyi Gu guleyi@aliyun.com Renji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center Shanghai China -